CLINICAL_TRIALS
trial_result
· 2023-08-14
Clinical Trial Update: Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) [Phase 2]
Summary
Phase 2 clinical trial of silmitasertib (CX-4945) in patients with severe COVID-19 was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arizona | Conditions: Coronavirus | Phase 2 | Status: TERMINATED | Results posted: 2023-08-14